1
/
of
1
Elabscience
SKU:E-CL-H1160
Human TFF2(Trefoil Factor 2) CLIA Kit
Human TFF2(Trefoil Factor 2) CLIA Kit
Regular price
$682.00 USD
Regular price
Sale price
$682.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Human TFF2 (Trefoil Factor 2) CLIA Kit, a cutting-edge solution designed to facilitate accurate and efficient measurement of TFF2 levels in human samples. This state-of-the-art kit is meticulously crafted to meet the highest standards of quality and reliability, ensuring precise and reproducible results.
The Human TFF2 CLIA Kit employs the Chemiluminescent Immunoassay (CLIA) technique, a highly sensitive and specific method for quantifying TFF2 levels. This advanced technology enables researchers and clinicians to gain valuable insights into the role of TFF2 in various physiological and pathological processes.
With its user-friendly design, the Human TFF2 CLIA Kit offers a streamlined workflow, minimizing the time and effort required for sample analysis. The kit includes all necessary components, meticulously optimized to ensure optimal performance and accuracy. From sample preparation to data interpretation, this comprehensive kit provides a seamless experience for researchers and clinicians alike.
The Human TFF2 CLIA Kit boasts exceptional sensitivity, with a lower limit of detection that enables the quantification of even trace amounts of TFF2 in human samples. This remarkable sensitivity empowers researchers to explore the intricate dynamics of TFF2 in diverse biological contexts, unraveling its potential as a biomarker or therapeutic target.
Furthermore, the Human TFF2 CLIA Kit exhibits outstanding specificity, ensuring minimal cross-reactivity with other molecules. This specificity guarantees the reliability and accuracy of TFF2 measurements, eliminating potential confounding factors and enabling precise data interpretation.
In summary, the Human TFF2 CLIA Kit represents a breakthrough in TFF2 analysis, offering researchers and clinicians a powerful tool to unravel the complexities of TFF2 biology. With its exceptional sensitivity, specificity, and user-friendly design, this kit is poised to revolutionize TFF2 research and contribute to advancements in various fields, including gastroenterology, oncology, and regenerative medicine.
The Human TFF2 CLIA Kit employs the Chemiluminescent Immunoassay (CLIA) technique, a highly sensitive and specific method for quantifying TFF2 levels. This advanced technology enables researchers and clinicians to gain valuable insights into the role of TFF2 in various physiological and pathological processes.
With its user-friendly design, the Human TFF2 CLIA Kit offers a streamlined workflow, minimizing the time and effort required for sample analysis. The kit includes all necessary components, meticulously optimized to ensure optimal performance and accuracy. From sample preparation to data interpretation, this comprehensive kit provides a seamless experience for researchers and clinicians alike.
The Human TFF2 CLIA Kit boasts exceptional sensitivity, with a lower limit of detection that enables the quantification of even trace amounts of TFF2 in human samples. This remarkable sensitivity empowers researchers to explore the intricate dynamics of TFF2 in diverse biological contexts, unraveling its potential as a biomarker or therapeutic target.
Furthermore, the Human TFF2 CLIA Kit exhibits outstanding specificity, ensuring minimal cross-reactivity with other molecules. This specificity guarantees the reliability and accuracy of TFF2 measurements, eliminating potential confounding factors and enabling precise data interpretation.
In summary, the Human TFF2 CLIA Kit represents a breakthrough in TFF2 analysis, offering researchers and clinicians a powerful tool to unravel the complexities of TFF2 biology. With its exceptional sensitivity, specificity, and user-friendly design, this kit is poised to revolutionize TFF2 research and contribute to advancements in various fields, including gastroenterology, oncology, and regenerative medicine.
Share
